loading page

TAFRO syndrome: a case report
  • +5
  • Shan Meng,
  • Hailing Liu,
  • Wang-Gang Zhang,
  • Aili He,
  • Honghong Sun,
  • Ru Zhang,
  • Xiaoli Chen,
  • Yinxia Chen
Shan Meng
Xi'an Jiaotong University Second Affiliated Hospital

Corresponding Author:[email protected]

Author Profile
Hailing Liu
Xi'an Jiaotong University
Author Profile
Wang-Gang Zhang
Xi'an Jiaotong University
Author Profile
Aili He
Xi'an Jiaotong University
Author Profile
Honghong Sun
Xi'an Jiaotong University
Author Profile
Ru Zhang
Xi'an Jiaotong University
Author Profile
Xiaoli Chen
Xi'an Jiaotong University
Author Profile
Yinxia Chen
Xi'an Jiaotong University
Author Profile

Abstract

A man diagnosed as TAFRO syndrome was successfully responded to a novel immunosuppressive regimen containing methylprednisolone and mycophenolate mofetil. Blood cells firstly recovered, followed by the general situation and complete recover 1 month later, highlighting the danger of TAFRO syndrome and the importance of immunosuppressive agents in reversing pathological course
07 Nov 2021Submitted to Clinical Case Reports
08 Nov 2021Submission Checks Completed
08 Nov 2021Assigned to Editor
10 Nov 2021Reviewer(s) Assigned
11 Jan 2022Review(s) Completed, Editorial Evaluation Pending
30 Jan 2022Editorial Decision: Revise Minor
28 Mar 20221st Revision Received
29 Mar 2022Submission Checks Completed
29 Mar 2022Assigned to Editor
29 Mar 2022Review(s) Completed, Editorial Evaluation Pending
21 May 2022Editorial Decision: Accept